Call 08048955608 72% Response Rate

Send Enquiry

our range

Pharmaceuticals Injection

Offering you a complete choice of products which include meropenem 1gm injection.

Meropenem 1gm Injection

  • Meropenem 1gm Injection
  • Meropenem 1gm Injection
  • Meropenem 1gm Injection
Meropenem 1gm Injection
Get Best Quote
Rs 1,100  / VialPrice on Request
Strength1 gm
Pack Size10 ml
Pack TypeVial
Brand NameMeropenem 1g
ManufacturerSignature Life Sciences
UsagesTreats severe bacterial infections, including pneumonia, sepsis, and UTIs
Prescription/Non PrescriptionPrescription
Shelf Life24 Months
Also GivesThird Party Manufacturing
Country of OriginMade in India

Abhiflax Pharma Chem is proud to serve as a trusted C&F Distributor for HAB Pharmaceuticals and Signature Lifesciences, delivering high-quality critical-care antibiotics to healthcare institutions across India. Among its essential offerings is Meropenem 1 g Injection, a broad-spectrum carbapenem antibiotic widely recognized for its powerful efficacy in the treatment of severe and life-threatening infections. With a strong focus on reliability, product integrity, and seamless supply-chain management, Abhiflax Pharma Chem ensures that this vital medication reaches hospitals and practitioners with the highest standards of quality and punctuality.

Meropenem, the active ingredient, is a beta-lactam antibiotic belonging to the carbapenem class. Known for its exceptional stability against extended-spectrum beta-lactamases (ESBLs), Meropenem offers clinicians a dependable solution for treating infections caused by resistant bacterial strains. The 1 g injection formulation is widely used in intensive care and emergency settings, providing rapid and effective coverage against a broad range of gram-positive, gram-negative, and anaerobic pathogens. This makes it a preferred choice for treating severe infections such as bacterial meningitis, complicated intra-abdominal infections, complicated urinary tract infections, skin and soft tissue infections, hospital-acquired pneumonia, and septicemia.

HAB Pharmaceuticals and Signature Lifesciences manufacture Meropenem 1 g Injection in state-of-the-art facilities that adhere strictly to global Good Manufacturing Practices (GMP). Every batch undergoes rigorous testing to ensure potency, purity, sterility, and stability. Their advanced production systems, combined with precise quality control procedures, guarantee that healthcare professionals receive a product that meets the most demanding therapeutic standards. The formulation is designed for optimal reconstitution, ensuring ease of use for clinicians and rapid administration in critical scenarios.

As the central C&F Distributor, Abhiflax Pharma Chem plays a crucial role in maintaining steady availability of Meropenem 1 g Injection across multiple regions. Equipped with advanced storage systems, temperature-controlled warehousing, and efficient distribution channels, the company ensures that the medication retains its quality throughout the logistics chain. Abhiflax Pharma Chem prides itself on timely order execution, dependable stock management, and consistent communication with distributors, hospitals, and pharmacies, making it a preferred supply partner in the pharmaceutical ecosystem.

Beyond distribution, Abhiflax Pharma Chem upholds a commitment to service excellence and ethical business practices. Its partnership with HAB Pharmaceuticals and Signature Lifesciences reflects a unified mission—to make high-quality, research-driven pharmaceutical products accessible to healthcare professionals who rely on precision and trust in every treatment decision. The company’s dedication to operational efficiency and customer satisfaction has positioned it as a dependable link between manufacturers and the healthcare sector.

In an era marked by rising antimicrobial resistance and increasing demand for advanced injectable therapies, Meropenem 1 g Injection distributed by Abhiflax Pharma Chem stands as a critical tool in modern medicine. With proven clinical performance, superior manufacturing quality, and robust distribution support, it continues to play a vital role in improving patient outcomes in hospitals and critical-care units nationwide.

View Complete details

Yes! I am Interested Request a call back

EXPLORE MORE CATEGORIES